Denali Therapeutics Inc at TD Cowen Healthcare Conference Transcript
I'm Joel. I'm one of the senior biotech analysts here on the team at TD Cowan. And it's my pleasure to have with me today, Denali Therapeutics, and up here with me we have co-founder, CFO and COO Alex Shuth. So thank you very much for being here. Maybe before we dive into the individual programs, if you want to just give a brief kind of high level overview of, kind of where the company's at and what we should expect for, The rest of 20, 2026.
Absolutely. I mean, first of all, Joe, thanks so much for the invitation to the conference and for the great coverage. Always. I do want to highlight the title of your last note which I really enjoyed. Must see TV Ready for prime time. So, thanks for that. So, 2026, we're very excited. It's a big year for us. It's actually we founded the company back in 2015 with the premise with the idea that technology.
That can deliver large molecules through the blood brain barrier and open up the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
